1 – 19 of 19
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia
(
- Contribution to journal › Article
- 2023
-
Mark
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
(
- Contribution to journal › Article
-
Mark
Microvascular Dysfunction and Reduced Cardiac Stress Reactivity in Postural Orthostatic Tachycardia Associated With Postacute COVID-19
(
- Contribution to journal › Article
-
Mark
Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome : a multi-omic profiling study
(
- Contribution to journal › Article
-
Mark
Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - insights from the IAMI trial
(
- Contribution to journal › Article
- 2022
-
Mark
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction : The phase 2a FLAVOUR study
(
- Contribution to journal › Article
- 2020
-
Mark
Design and rationale of FLAVOUR : A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction
(
- Contribution to journal › Article
- 2019
-
Mark
Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events
(
- Contribution to journal › Article
- 2017
-
Mark
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Oxygen therapy in suspected acute myocardial infarction
(
- Contribution to journal › Article
- 2016
-
Mark
Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT.
(
- Contribution to journal › Article
- 2013
-
Mark
Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction
(
- Contribution to journal › Article
- 2012
-
Mark
Effects of Myocardial Postconditioning on the Recruitment of Endothelial Progenitor Cells.
(
- Contribution to journal › Article
-
Mark
Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Myocardium at risk by magnetic resonance imaging: head-to-head comparison of T2-weighted imaging and contrast-enhanced steady-state free precession.
2012) In European Heart Journal-Cardiovascular Imaging(
- Contribution to journal › Article
- 2010
-
Mark
An automatic method for quantification of myocardium at risk from myocardial perfusion SPECT in patients with acute coronary occlusion.
(
- Contribution to journal › Article
-
Mark
Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography
(
- Contribution to journal › Article
-
Mark
Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction
(
- Contribution to journal › Article
- 2009
-
Mark
Effect of Postconditioning on Infarct Size in Patients With ST-elevation Myocardial Infarction
(
- Contribution to journal › Published meeting abstract